<DOC>
	<DOCNO>NCT00708617</DOCNO>
	<brief_summary>Apart Fibrotest , non-invasive marker validate chronic hepatitis C. However chronic C hepatitis , non invasive test ( Fibrotest transient elastometry ) already use current practice . The aim study validate diagnostic value FIBROSCAN comparison liver histology . FIBROSCAN also compare Fibrotest FIBROSCAN-Fibrotest association test alone order optimize diagnostic strategy . Studied variable significant fibrosis ( ≥ 2 METAVIR score ) presence cirrhosis ( score : F4 ) . Diagnostic value score express sensitivity , specificity , positive negative predictive value , ROC curve . Areas ROC curve score compare use Z test .</brief_summary>
	<brief_title>FIBROSCAN Validation Interest Fibrotest - FIBROSCAN Association Fibrosis Diagnosis Alcoholic Liver Disease</brief_title>
	<detailed_description>Alcoholic liver disease ( ALD ) highly prevalent liver fibrosis cirrhosis asymptomatic long time . Liver biopsy patient ALD design determine prognostic liver lesion manage cirrhosis . Apart Fibrotest , non-invasive marker validate chronic hepatitis C. However chronic C hepatitis , non invasive test ( Fibrotest transient elastometry ) already use current practice . The aim study validate diagnostic value FIBROSCAN comparison liver histology . FIBROSCAN also compare Fibrotest FIBROSCAN-Fibrotest association test alone order optimize diagnostic strategy . 200 consecutive excessive drinker aminotransferase anomaly suspicion cirrhosis include study period 2 year . All patient intercostal liver biopsy , assessment non-invasive biological score liver fibrosis transient elastography . Studied variable significant fibrosis ( ≥ 2 METAVIR score ) presence cirrhosis ( score : F4 ) . Diagnostic value score express sensitivity , specificity , positive negative predictive value , ROC curve . Areas ROC curve score compare use Z test . Multivariate analysis use identify score independent diagnostic value therefore could associate . This study allow select non-invasive marker ( ) best diagnostic value order identify early fibrosis patient ALD .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Liver Diseases , Alcoholic</mesh_term>
	<criteria>consecutive excessive drinker gender age 18 75 year , hospitalize manage alcoholic liver disease Ag HBs , HIV , HCV , without liver disease alcohol abuse , alcohol consumption great 80 g per day least 5 year aminotransferase level anomaly ( ASAT ≥ 1.5 N ALAT &gt; N ) suspicion cirrhosis liver disease alcohol abuse , ascitis , contraindication intercostal liver biopsy IMC &gt; 30 liver carcinoma carcinoma serious associate disease platelet &lt; 60 GIGAS/L Quick time &lt; 50 % TCA &gt; 1.5 witness time treatment Plavix® platelet antiaggregant anticoagulant intercostal liver biopsy refusal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Liver fibrosis</keyword>
	<keyword>Alcoholic liver disease</keyword>
	<keyword>Non invasive diagnostic method</keyword>
	<keyword>Transient elastography</keyword>
	<keyword>Fibrotest</keyword>
</DOC>